Purchase Order 75D30124P00055
Award Date 7/29/24
Potential Completion Date 9/30/24
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention awarded a $60.5K firm fixed-price purchase order to Luminex Corp on September 8, 2025, for two Luminex MAGPIX xPONENT Systems, with completion scheduled for November 15, 2025. This sole-source award was justified under Federal Acquisition Regulation 13.106-1(b)(1)(i) authority, as the CDC determined that only Luminex Corporation can manufacture and provide the specialized analytical laboratory instruments required for biosafety level-3 laboratory...
- The Centers for Disease Control and Prevention (CDC) awarded a $77,468.82 firm fixed price purchase order to Luminex Corporation for MAGPIX and reagent lab supplies. The CDC, located within the Department of Health and Human Services, will utilize these products to support its infectious disease prevention and control programs conducted from its Pittsburgh location. Luminex will deliver the requested supplies from its production facilities in Austin, Texas by October 27, 2023 to meet the CDC's...
- The Centers for Disease Control and Prevention (CDC) awarded a $66.9K firm fixed-price purchase order to Luminex Corp on August 2, 2024, for the development and delivery of HIV assay protocols and related technical documentation. The scope encompasses client data analysis files, coupling protocols, bead drying protocols, assay protocols, buffer formulation protocols, and reagent and plasma storage, handling, and preparation protocols. The contract extends through December 9, 2029, and will be...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
- The Centers for Disease Control and Prevention (CDC) awarded a $79,711 firm-fixed-price purchase order contract to Luminex Corporation for annual services. The contract has an ultimate completion date of April 30, 2026. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions, and often serves as a prime contractor delivering specialized multiplexing systems to federal agencies. This contract is not designated as a set-aside requirement. Luminex...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $7,950.00 firm fixed-price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of diagnostic technologies, for an annual service contract for Luminex 200 equipment. The contract, which runs through April 29, 2025, does not have a small business set-aside designation. Luminex is an established federal contractor, holding several indefinite delivery vehicles (IDVs) with agencies like the U.S....
- This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $148,550.00 firm fixed price purchase order to Luminex Corporation, a for-profit foreign-owned manufacturer, for a Gastrointestinal Pathogen Panel. This competitive contract does not utilize a set-aside. Luminex provides proprietary multiplexing technologies, diagnostic assays, and related products to support clinical testing and biomedical research efforts across various federal agencies including...
- This is a $97,636.38 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for the provision of lab supplies, and is not set aside. Luminex has previously provided the CDC, as well as other federal agencies like the Department of Veterans Affairs and Department of Defense, with immunology services, laboratory supplies,...